Why the study?
POTS is associated with autonomic symptoms, including GI complaints, and has been linked to insulin resistance, but the role of metabolic hormones and their link to hemodynamics and GI symptoms remains unclear.
Are metabolic hormones and HbA1c associated with hemodynamic parameters and gastrointestinal symptoms in patients with POTS?
Are metabolic hormones and HbA1c associated with hemodynamic parameters and gastrointestinal symptoms in patients with POTS?
Fasting C-peptide and insulin levels correlate with blood pressure in POTS patients, suggesting a potential link between insulin-related pathways and blood pressure regulation in this condition.
Answers are grounded in this paper and cite their sources.
Association warrants no immediate clinical action; leaves open metabolic contributions to POTS hemodynamics.
Postural orthostatic tachycardia syndrome (POTS) is associated with multiple autonomic symptoms, including gastrointestinal (GI) complaints, and has been linked to insulin resistance. We aimed to explore HbA1c, circulating metabolic hormones (insulin, C-peptide, GIP, GLP-1, glucagon, leptin, and peptide YY) and cortisol, and their associations with hemodynamic parameters and GI symptoms in POTS. Two POTS cohorts were studied and compared with matched controls. In the fasting cohort, blood samples were drawn in 42 patients and 41 controls, followed by active standing tests with measurement of pulse and blood pressure (BP) in supine and standing positions. In the non-fasting cohort, questionnaires assessed GI symptoms and HbA1c was measured in 43 patients and 52 controls. Fasting C-peptide and insulin levels correlated with BP in POTS (q = 0.002) but not in controls. Fasting insulin tended to be higher in POTS but was not statistically significant after adjustment for BMI (β = 6.85; 95% CI: -1.04-14.74; p = 0.085). Morning cortisol was comparable between groups. In the non-fasting cohort, HbA1c and metabolic hormones were comparable between groups, with no associations with GI symptoms. Together, these findings suggest a potential link between insulin-related pathways and BP regulation in POTS. Future studies are warranted to further investigate insulin dynamics in POTS.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: